Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory Neuroblastoma

Nanjing Children's Hospital · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
neuroblastoma, recurrent, refractory, chimeric natural killer receptor universal t-cells, relapsed/refractory neuroblastoma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 839788
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.